Další formáty:
BibTeX
LaTeX
RIS
@article{1672824, author = {Romžová, Marianna and Smitalová, Dagmar and Tom, Nikola and Jurček, Tomáš and Čulen, Martin and Žáčková, Daniela and Mayer, Jiří and Ráčil, Zdeněk}, article_location = {England}, article_number = {3}, doi = {http://dx.doi.org/10.1111/bjh.16382}, keywords = {next generation sequencing; illumina; BCR-ABL1; kinase domain mutation; TKI resistance}, language = {eng}, issn = {0007-1048}, journal = {British journal of haematology}, title = {Novel Illumina-based next generation sequencing approach with one-round amplification provides early and reliable detection of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia}, url = {https://onlinelibrary.wiley.com/doi/full/10.1111/bjh.16382}, volume = {189}, year = {2020} }
TY - JOUR ID - 1672824 AU - Romžová, Marianna - Smitalová, Dagmar - Tom, Nikola - Jurček, Tomáš - Čulen, Martin - Žáčková, Daniela - Mayer, Jiří - Ráčil, Zdeněk PY - 2020 TI - Novel Illumina-based next generation sequencing approach with one-round amplification provides early and reliable detection of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia JF - British journal of haematology VL - 189 IS - 3 SP - 469-474 EP - 469-474 PB - Wiley-Blackwell SN - 00071048 KW - next generation sequencing KW - illumina KW - BCR-ABL1 KW - kinase domain mutation KW - TKI resistance UR - https://onlinelibrary.wiley.com/doi/full/10.1111/bjh.16382 L2 - https://onlinelibrary.wiley.com/doi/full/10.1111/bjh.16382 N2 - The occurrence of mutations in the BCR-ABL1 kinase domain (KD) can lead to treatment resistance in chronic myeloid leukaemia patients. Nowadays, next-generation sequencing (NGS) is an alternative method for the detection of kinase domain mutations, compared to routinely used Sanger sequencing, providing a higher sensitivity of mutation detection. However, in the protocols established so far multiple rounds of amplification limit reliable mutation detection to approximately 5% variant allele frequency. Here, we present a simplified, one-round amplification NGS protocol for the Illumina platform, which offers a robust early detection of BCR-ABL1 KD mutations with a reliable detection limit of 3% variant allele frequency. ER -
ROMŽOVÁ, Marianna, Dagmar SMITALOVÁ, Nikola TOM, Tomáš JURČEK, Martin ČULEN, Daniela ŽÁČKOVÁ, Jiří MAYER a Zdeněk RÁČIL. Novel Illumina-based next generation sequencing approach with one-round amplification provides early and reliable detection of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia. \textit{British journal of haematology}. England: Wiley-Blackwell, 2020, roč.~189, č.~3, s.~469-474. ISSN~0007-1048. Dostupné z: https://dx.doi.org/10.1111/bjh.16382.
|